Table
of Contents
95
Exhibit No.
Description
10.14*
Form of market stock unit award agreement under the Biogen Idec Inc. 2008 Omnibus
Equity Plan. Filed as Exhibit 10.3 to our Quarterly Report on Form 10-Q for the quarter
ended March 31, 2014.
10.15*
Form of restricted stock unit award agreement under the Biogen Idec Inc. 2008 Omnibus
Equity Plan. Filed as Exhibit 10.1 to our Current Report on Form 8-K filed on August 1,
2008.
10.16*
Form of nonqualified stock option award agreement under the Biogen Idec Inc. 2008
Omnibus Equity Plan. Filed as Exhibit 10.2 to our Current Report on Form 8-K filed on
August 1, 2008.
10.17*
Form of cash-settled performance shares award agreement under the Biogen Idec Inc.
2008 Omnibus Equity Plan. Filed as Exhibit 10.1 to our Quarterly Report on Form 10-Q for
the quarter ended March 31, 2010.
10.18*
Biogen Inc. 2006 Non-Employee Directors Equity Plan, as amended. Filed as Exhibit 10.1
to our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.
10.19*
Biogen Inc. 2015 Employee Stock Purchase Plan. Filed as Appendix A to our Definitive
Proxy Statement on Schedule 14A filed on April 30, 2015.
10.20*
Biogen Idec Inc. 2008 Performance-Based Management Incentive Plan. Filed as Appendix
B to our Definitive Proxy Statement on Schedule 14A filed on May 8, 2008.
10.21*
Biogen Idec Inc. Voluntary Executive Supplemental Savings Plan, as amended and restated
effective January 1, 2004. Filed as Exhibit 10.13 to our Annual Report on Form 10-K for
the year ended December 31, 2003.
10.22*
Biogen Idec Inc. Supplemental Savings Plan, as amended. Filed as Exhibit 10.23 to our
Annual Report on Form 10-K for the year ended December 31, 2015.
10.23*
Biogen Idec Inc. Voluntary Board of Directors Savings Plan, as amended. Filed as Exhibit
10.24 to our Annual Report on Form 10-K for the year ended December 31, 2015.
10.24*
Biogen Idec Inc. Executive Severance Policy - U.S. Executive Vice President, as amended
effective January 1, 2014. Filed as Exhibit 10.39 to our Annual Report on Form 10-K for
the year ended December 31, 2013.
10.25*
Biogen Idec Inc. Executive Severance Policy - International Executive Vice President, as
amended effective January 1, 2014. Filed as Exhibit 10.40 to our Annual Report on Form
10-K for the year ended December 31, 2013.
10.26*
Biogen Idec Inc. Executive Severance Policy - U.S. Senior Vice President, as amended
effective October 13, 2008. Filed as Exhibit 10.53 to our Annual Report on Form 10-K for
the year ended December 31, 2008.
10.27*
Biogen Idec Inc. Executive Severance Policy - International Senior Vice President, as
amended effective October 13, 2008. Filed as Exhibit 10.54 to our Annual Report on Form
10-K for the year ended December 31, 2008.
10.28*+
Annual Retainer Summary for Board of Directors.
10.29*
Form of indemnification agreement for directors and executive officers. Filed as Exhibit
10.1 to our Current Report on Form 8-K filed on June 7, 2011.
10.30*
Employment Agreement between Biogen Inc. and Michel Vounatsos dated December 18,
2016. Filed as Exhibit 10.1 to our Current Report on Form 8-K filed on December 19,
2016.
10.31*+
Letter regarding employment arrangement of Jeffrey Capello dated November 14, 2017.
10.32*+
Letter regarding employment arrangement of Gregory Covino dated February 25, 2012.
10.33*+
Letter regarding employment arrangement of Michael Ehlers dated April 16, 2016.
10.34*
Letter regarding employment arrangement of Susan Alexander dated December 31, 2005.
Filed as Exhibit 10.58 to our Annual Report on Form 10-K for the year ended December
31, 2009.
10.35*
Employment Agreement between Biogen Idec. Inc. and George A. Scangos amended as
of August 23, 2013. Filed as Exhibit 10.1 to our Current Report on Form 8-K filed on August
26, 2013.
10.36*
Letter regarding employment arrangement of Paul J. Clancy dated August 17, 2007. Filed
as Exhibit 10.49 to our Annual Report on Form 10-K for the year ended December 31,
2007.
10.37*
Letter regarding employment arrangement of John Cox dated May 19, 2016. Filed as Exhibit
10.1 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2016.